Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria

Fauzia K Musasia, Irene N Nkumama, Roland Frank, Victor Kipkemboi, Martin Schneider, Kennedy Mwai, Dennis O Odera, Micha Rosenkranz, Kristin Fürle, Domitila Kimani, James Tuju, Patricia Njuguna, Mainga Hamaluba, Melissa C Kapulu, Hedda Wardemann, CHMI-SIKA Study Team, Faith H A Osier, Abdirahman I Abdi, Yonas Abebe, Philip Bejon, Peter F Billingsley, Peter C Bull, Zaydah de Laurent, Stephen L Hoffman, Eric R James, Silvia Kariuki, Rinter Kimathi, Sam Kinyanjui, Cheryl Kivisi, Johnstone Makale, Kevin Marsh, Khadija Said Mohammed, Moses Mosobo, Janet Musembi, Jennifer Musyoki, Michelle Muthui, Jedidah Mwacharo, Francis Ndungu, Joyce M Ngoi, Omar Ngoto, Bernhards Ogutu, Fredrick Olewe, Donwilliams Omuoyo, John Ong'echa, Edward Otieno, Jimmy Shangala, Betty Kim Lee Sim, Thomas L Richie, Juliana Wambua, Thomas N Williams, Fauzia K Musasia, Irene N Nkumama, Roland Frank, Victor Kipkemboi, Martin Schneider, Kennedy Mwai, Dennis O Odera, Micha Rosenkranz, Kristin Fürle, Domitila Kimani, James Tuju, Patricia Njuguna, Mainga Hamaluba, Melissa C Kapulu, Hedda Wardemann, CHMI-SIKA Study Team, Faith H A Osier, Abdirahman I Abdi, Yonas Abebe, Philip Bejon, Peter F Billingsley, Peter C Bull, Zaydah de Laurent, Stephen L Hoffman, Eric R James, Silvia Kariuki, Rinter Kimathi, Sam Kinyanjui, Cheryl Kivisi, Johnstone Makale, Kevin Marsh, Khadija Said Mohammed, Moses Mosobo, Janet Musembi, Jennifer Musyoki, Michelle Muthui, Jedidah Mwacharo, Francis Ndungu, Joyce M Ngoi, Omar Ngoto, Bernhards Ogutu, Fredrick Olewe, Donwilliams Omuoyo, John Ong'echa, Edward Otieno, Jimmy Shangala, Betty Kim Lee Sim, Thomas L Richie, Juliana Wambua, Thomas N Williams

Abstract

Ring-infected erythrocytes are the predominant asexual stage in the peripheral circulation but are rarely investigated in the context of acquired immunity against Plasmodium falciparum malaria. Here we compare antibody-dependent phagocytosis of ring-infected parasite cultures in samples from a controlled human malaria infection (CHMI) study (NCT02739763). Protected volunteers did not develop clinical symptoms, maintained parasitaemia below a predefined threshold of 500 parasites/μl and were not treated until the end of the study. Antibody-dependent phagocytosis of both ring-infected and uninfected erythrocytes from parasite cultures was strongly correlated with protection. A surface proteomic analysis revealed the presence of merozoite proteins including erythrocyte binding antigen-175 and -140 on ring-infected and uninfected erythrocytes, providing an additional antibody-mediated protective mechanism for their activity beyond invasion-inhibition. Competition phagocytosis assays support the hypothesis that merozoite antigens are the key mediators of this functional activity. Targeting ring-stage parasites may contribute to the control of parasitaemia and prevention of clinical malaria.

Conflict of interest statement

B.K.L.S., Y.A., P.F.B., S.L.H, E.R.J., TR. are salaried, full-time employees of Sanaria Inc., the manufacturer of Sanaria PfSPZ Challenge. Thus, all authors associated with Sanaria Inc. have potential conflicts of interest. All other authors declare no competing interests.

© 2022. The Author(s).

Figures

Fig. 1. Detection of antibody binding to…
Fig. 1. Detection of antibody binding to ring-infected erythrocytes (rIEs).
Malaria-immune plasma shows modest to low levels of binding to rIEs in comparison to mIEs in immunofluorescence assays. No binding detected with malaria-naive serum or with the secondary antibody in the absence of malaria-immune plasma. Representative data from 3 independent experiments with similar results. Source data are provided as a Source Data file.
Fig. 2. Characteristics of antibodies binding to…
Fig. 2. Characteristics of antibodies binding to rIEs.
A IgG antibody binding to rIEs was dose-dependent in human control samples. Error bars show the mean and standard error of the mean (SEM). N = 3 biologically independent controls were analyzed in duplicate in n = 2 independent experiments. Positive controls were pooled hyperimmune serum (PHIS, red lines) and malaria-immune globulin (MIG, blue lines), while negative controls were pooled malaria-naive serum (naive, black lines). IgG antibody binding to rIEs was strongly correlated between B field and laboratory isolates, as well as with IgG binding to C mIEs and D merozoites. Each black dot in 2B-D shows the level of antibody binding in biologically independent human samples (n = 37) from the Junju cohort to rIEs from laboratory or field isolates or to merozoites. Laboratory isolate refers to the FCR-3 strain of P. falciparum. Merozoites were of the NF54 strain used in the CHMI study. Correlations from single experiments conducted with n = 2 technical replicates per sample per assay in 2B-D were tested using Spearman’s R. Source data are provided as a Source Data file.
Fig. 3. Opsonic phagocytosis of ring-infected and…
Fig. 3. Opsonic phagocytosis of ring-infected and uninfected erythrocytes predicts protection.
The relative phagocytosis index (RPI) for ring-infected erythrocytes (rIEs) A or uninfected erythrocytes (uEs) D was compared between plasma samples from volunteers that did (n = 56, closed circles) or did not (n = 86, open circles) require treatment after a malaria challenge. Data points represent a total of N = 142 biologically independent samples tested in a single experiment with two technical replicates. The red lines indicate the median and 95% confidence intervals. Dotted horizontal lines indicate the seropositivity level (mean plus three standard deviations of malaria-naive plasma) for phagocytosis. P value determined by two-tailed Mann–Whitney U test with no adjustment for multiple comparisons. Sub-group analysis for rIEs (B) and uEs (E) respectively for treated volunteers who either developed fever (febrile, n = 26, red circles) or did not (non-febrile, n = 30, blue triangles), and for untreated volunteers in whom parasites were either detected by PCR (PCR + ve, n = 53, purple triangles) or remained negative (PCR-ve, n = 33, orange diamonds). Data points represent a total of N = 142 biologically independent samples tested in a single experiment with two technical replicates. The black lines indicate the median and 95% confidence intervals. Dotted horizontal lines indicate the seropositivity level for phagocytosis. P values were determined by Kruskal–Wallis two-sided test followed by Dunn’s multiple comparison test. C & F Kaplan–Meier curves for the time to treatment for volunteers with a high (n = 125, black line) versus low (n = 17, red line) RPI against rIEs, and a high (n = 104, black line) versus low (n = 38, red line) RPI against uEs, respectively. A total of N = 142 biologically independent samples were analysed in n = 2 independent experiments with n = 2 technical replicates per experiment. P value determined by log-rank test in a Kaplan–Meier survival analysis and not adjusted for confounding variables. Source data are provided as a Source Data file.
Fig. 4. Merozoite antigens are likely targets…
Fig. 4. Merozoite antigens are likely targets of antibody-dependent opsonic phagocytosis of ring-infected and uninfected erythrocytes.
A Phagocytosis of freshly isolated uEs that were pre-incubated with supernatants from mid-cycle parasite cultures (10 h to 34 h, blue circles), peri-invasion cultures (35 h to 10 h post invasion, red triangles), and fresh culture media (black squares). P values from a one-way ANOVA test followed by Tukey’s multiple comparison test. The graph shows the mean and error bars indicate the standard deviation. Each data point represents one of three biological replicates. B Phagocytosis of rIEs is strongly correlated with total IgG antibody binding to merozoites (n = 142). Each black dot indicates the level of IgG binding to either merozoites or RPI (%) of uEs in a total of N = 142 biologically independent samples, tested in a single experiment in duplicate. Correlation is tested using Spearmans’ R. The RPI of C uEs and D rIEs using individual plasma samples (n = 6) before (pre) and after (post) competition with individual and pooled recombinant merozoite antigens. Coloured symbols denote individual samples with high (n = 2, red), medium (n = 2, blue) and low (n = 2, black) levels of IgG against merozoites, respectively. P values were determined using a two-tailed paired t-test. Each data point represents the RPI measured once for each plasma sample with two technical replicates. RPI, relative phagocytosis index. Source data are provided as a Source Data file.
Fig. 5. Volcano plots demonstrate significant enrichment…
Fig. 5. Volcano plots demonstrate significant enrichment of distinct merozoite proteins in specific experimental conditions.
Each panel shows the abundance of individual proteins after a comparative analysis of the following experimental conditions (x-axis): A ring cultures versus mock-shaved ring cultures, B ring cultures versus uEs in fresh media, C uEs in used media versus uEs in fresh media, and D uEs in used media versus ring cultures. Black and green dots in each panel indicate the Plasmodial and human proteins, respectively that were detected significantly more abundantly in one experimental condition compared to the other. Grey dots indicate proteins that were not detected differentially in the respective experimental conditions. For each panel, subheadings are the suggested localisation of the Plasmodium proteins shown in black. The negative Log10 p-values are displayed on the y-axis and the Log2-fold changes are displayed on the x-axis. The dotted red lines indicate the 0.05% FDR significance cut-off. Differences between pairs of treatment conditions were calculated using two-sample t-tests without correction for multiple comparisons. Four independent biological replicates were analysed for each experimental condition. Source data are uploaded onto the PRIDE database.
Fig. 6. Association of phagocytosis of rIEs…
Fig. 6. Association of phagocytosis of rIEs and uEs with high haemoglobin levels in CHMI individuals.
A Hb levels were measured once in biologically independent blood samples from volunteers (n = 142) at n = 2-time points on the day before the challenge (C-1, open squares) and the day of discharge (DOD, closed squares). Each data point represents the Hb level from independent volunteers at distinct time points. Red lines indicate the mean and 95% confidence intervals. P value determined by a two-sided Wilcoxon signed-rank t test for matched pairs. B Hb levels measured on DOD subtracted from those on C-1 for treated (n = 56, closed circles) versus non-treated (n = 86, open circles) volunteers. Each data point represents the difference in Hb levels between C-1 and DOD for each volunteer. Red lines indicate the mean and 95% confidence intervals. The dotted horizontal line indicates no difference between C-1 and DOD. The P value comparing the decrease in Hb was determined by a two-tailed Mann–Whitney U test. C Sub-group analysis for a decrease in Hb for treated volunteers who either developed fever (febrile, n = 26, red circles) or did not (non-febrile, n = 30, blue triangles), and untreated volunteers in whom parasites were either detected by PCR (PCR + ve, n = 53, purple triangles) or remained negative (PCR-ve, n = 33, orange diamonds). Each data point represents the difference in Hb levels between C-1 and DOD. Black lines indicate the mean and 95% confidence intervals. P values comparing the decrease in Hb were determined by the Kruskal–Wallis test followed by Dunn’s multiple comparison test. Source data are provided as a Source Data file.

References

    1. Cowman AF, Healer J, Marapana D, Marsh K. Malaria: biology and disease. Cell. 2016;167:610–624. doi: 10.1016/j.cell.2016.07.055.
    1. Yazdani SS, Mukherjee P, Chauhan VS, Chitnis CE. Immune responses to asexual blood-stages of malaria parasites. Curr. Mol. Med. 2006;6:187–203. doi: 10.2174/156652406776055212.
    1. Douki JB, et al. Adhesion of normal and Plasmodium falciparum ring-infected erythrocytes to endothelial cells and the placenta involves the rhoptry-derived ring surface protein-2. Blood. 2003;101:5025–5032. doi: 10.1182/blood-2002-12-3710.
    1. Pouvelle B, Buffet PA, Lepolard C, Scherf A, Gysin J. Cytoadhesion of Plasmodium falciparum ring-stage-infected erythrocytes. Nat. Med. 2000;6:1264–1268. doi: 10.1038/81374.
    1. Buffet PA, et al. Ex vivo perfusion of human spleens maintains clearing and processing functions. Blood. 2006;107:3745–3752. doi: 10.1182/blood-2005-10-4094.
    1. Safeukui I, et al. Retention of Plasmodium falciparum ring-infected erythrocytes in the slow, open microcirculation of the human spleen. Blood. 2008;112:2520–2528. doi: 10.1182/blood-2008-03-146779.
    1. Layez C, et al. Plasmodium falciparum rhoptry protein RSP2 triggers destruction of the erythroid lineage. Blood. 2005;106:3632–3638. doi: 10.1182/blood-2005-04-1574.
    1. Perrin LH, Dayal R. Immunity to asexual erythrocytic stages of Plasmodium falciparum: role of defined antigens in the humoral response. Immunol. Rev. 1982;61:245–269. doi: 10.1111/j.1600-065X.1982.tb00379.x.
    1. Owusu-Agyei S, et al. Incidence of symptomatic and asymptomatic Plasmodium falciparum infection following curative therapy in adult residents of Northern Ghana. Am. J. Trop. Med. Hyg. 2001;65:197–203. doi: 10.4269/ajtmh.2001.65.197.
    1. Awah N, et al. Antibodies to the Plasmodium falciparum rhoptry protein RAP-2/RSP-2 in relation to anaemia in Cameroonian children. Parasite Immunol. 2011;33:104–115. doi: 10.1111/j.1365-3024.2010.01259.x.
    1. Awah NW, Troye-Blomberg M, Berzins K, Gysin J. Mechanisms of malarial anaemia: potential involvement of the Plasmodium falciparum low molecular weight rhoptry-associated proteins. Acta Trop. 2009;112:295–302. doi: 10.1016/j.actatropica.2009.08.017.
    1. Teo A, Feng G, Brown GV, Beeson JG, Rogerson SJ. Functional antibodies and protection against blood-stage malaria. Trends Parasitol. 2016;32:887–898. doi: 10.1016/j.pt.2016.07.003.
    1. Celada A, Cruchaud A, Perrin LH. Opsonic activity of human immune serum on in vitro phagocytosis of Plasmodium falciparum infected red blood cells by monocytes. Clin. Exp. Immunol. 1982;47:635–644.
    1. Chan CL, Renia L, Tan KS. A simplified, sensitive phagocytic assay for malaria cultures facilitated by flow cytometry of differentially-stained cell populations. PLoS One. 2012;7:e38523. doi: 10.1371/journal.pone.0038523.
    1. Kapulu, M. C. et al. Safety and PCR monitoring in 161 semi-immune Kenyan adults following controlled human malaria infection. JCI Insight6, 10.1172/jci.insight.146443 (2021).
    1. Cowman AF, Tonkin CJ, Tham WH, Duraisingh MT. The molecular basis of erythrocyte invasion by malaria parasites. Cell Host Microbe. 2017;22:232–245. doi: 10.1016/j.chom.2017.07.003.
    1. Chan JA, et al. Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity. J. Clin. Invest. 2012;122:3227–3238. doi: 10.1172/JCI62182.
    1. Camus D, Hadley TJ. A Plasmodium falciparum antigen that binds to host erythrocytes and merozoites. Science. 1985;230:553–556. doi: 10.1126/science.3901257.
    1. Sim BK, et al. Delineation of stage-specific expression of Plasmodium falciparum EBA-175 by biologically functional region II monoclonal antibodies. PLoS One. 2011;6:e18393. doi: 10.1371/journal.pone.0018393.
    1. Osier FH, et al. Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria. BMC Med. 2014;12:108. doi: 10.1186/1741-7015-12-108.
    1. Blackman MJ, Heidrich HG, Donachie S, McBride JS, Holder AA. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 1990;172:379–382. doi: 10.1084/jem.172.1.379.
    1. Bhowmick IP, Kumar N, Sharma S, Coppens I, Jarori GK. Plasmodium falciparum enolase: stage-specific expression and sub-cellular localization. Malar. J. 2009;8:179. doi: 10.1186/1475-2875-8-179.
    1. Ito, D., Schureck, M. A. & Desai, S. A. An essential dual-function complex mediates erythrocyte invasion and channel-mediated nutrient uptake in malaria parasites. Elife6, 10.7554/eLife.23485 (2017).
    1. Thompson JK, Triglia T, Reed MB, Cowman AF. A novel ligand from Plasmodium falciparum that binds to a sialic acid-containing receptor on the surface of human erythrocytes. Mol. Microbiol. 2001;41:47–58. doi: 10.1046/j.1365-2958.2001.02484.x.
    1. Sterkers Y, et al. Members of the low-molecular-mass rhoptry protein complex of Plasmodium falciparum bind to the surface of normal erythrocytes. J. Infect. Dis. 2007;196:617–621. doi: 10.1086/519685.
    1. Hill DL, et al. Opsonising antibodies to P. falciparum merozoites associated with immunity to clinical malaria. PLoS One. 2013;8:e74627. doi: 10.1371/journal.pone.0074627.
    1. Chan JA, et al. Antibody targets on the Surface of Plasmodium falciparum-infected erythrocytes that are associated with immunity to severe malaria in young children. J. Infect. Dis. 2019;219:819–828. doi: 10.1093/infdis/jiy580.
    1. Steel, R. W. et al. An opsonic phagocytosis assay for plasmodium falciparum sporozoites. Clin Vaccine Immunol24, 10.1128/CVI.00445-16 (2017).
    1. Chaudhury S, et al. The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity. Malar. J. 2016;15:301. doi: 10.1186/s12936-016-1348-9.
    1. Healer J, Graszynski A, Riley E. Phagocytosis does not play a major role in naturally acquired transmission-blocking immunity to Plasmodium falciparum malaria. Infect. Immun. 1999;67:2334–2339. doi: 10.1128/IAI.67.5.2334-2339.1999.
    1. Gardner JP, Pinches RA, Roberts DJ, Newbold CI. Variant antigens and endothelial receptor adhesion in Plasmodium falciparum. Proc. Natl Acad. Sci. USA. 1996;93:3503–3508. doi: 10.1073/pnas.93.8.3503.
    1. Perlmann H, et al. Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum. J. Exp. Med. 1984;159:1686–1704. doi: 10.1084/jem.159.6.1686.
    1. Bournazos S, Gupta A, Ravetch JV. The role of IgG Fc receptors in antibody-dependent enhancement. Nat. Rev. Immunol. 2020;20:633–643. doi: 10.1038/s41577-020-00410-0.
    1. Cooper JA, et al. The 140/130/105 kilodalton protein complex in the rhoptries of Plasmodium falciparum consists of discrete polypeptides. Mol. Biochem Parasitol. 1988;29:251–260. doi: 10.1016/0166-6851(88)90080-1.
    1. Sam-Yellowe TY, Shio H, Perkins ME. Secretion of Plasmodium falciparum rhoptry protein into the plasma membrane of host erythrocytes. J. Cell Biol. 1988;106:1507–1513. doi: 10.1083/jcb.106.5.1507.
    1. Counihan, N. A. et al. Plasmodium falciparum parasites deploy RhopH2 into the host erythrocyte to obtain nutrients, grow and replicate. Elife6, 10.7554/eLife.23217 (2017).
    1. Sherling, E. S. et al. The Plasmodium falciparum rhoptry protein RhopH3 plays essential roles in host cell invasion and nutrient uptake. Elife6, 10.7554/eLife.23239 (2017).
    1. Beeson, J. G. et al. Challenges and strategies for developing efficacious and long-lasting malaria vaccines. Sci. Transl. Med.11, 10.1126/scitranslmed.aau1458 (2019).
    1. Duffy PE, Patrick Gorres J. Malaria vaccines since 2000: progress, priorities, products. NPJ Vaccines. 2020;5:48. doi: 10.1038/s41541-020-0196-3.
    1. Chitnis CE, et al. Phase I clinical trial of a recombinant blood stage vaccine candidate for plasmodium falciparum malaria based on MSP1 and EBA175. PLoS One. 2015;10:e0117820. doi: 10.1371/journal.pone.0117820.
    1. El Sahly HM, et al. Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemic. Clin. Vaccin. Immunol. 2010;17:1552–1559. doi: 10.1128/CVI.00082-10.
    1. Koram KA, et al. Safety and immunogenicity of EBA-175 RII-NG malaria vaccine administered intramuscularly in semi-immune adults: a phase 1, double-blinded placebo controlled dosage escalation study. PLoS One. 2016;11:e0163066. doi: 10.1371/journal.pone.0163066.
    1. Franca, C. T. et al. Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development. Elife6, 10.7554/eLife.28673 (2017).
    1. Osier FH, et al. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect. Immun. 2008;76:2240–2248. doi: 10.1128/IAI.01585-07.
    1. Dutta S, et al. Strain-transcending neutralization of malaria parasite by antibodies against Plasmodium falciparum enolase. Malar. J. 2018;17:304. doi: 10.1186/s12936-018-2455-6.
    1. Pal-Bhowmick I, Mehta M, Coppens I, Sharma S, Jarori GK. Protective properties and surface localization of Plasmodium falciparum enolase. Infect. Immun. 2007;75:5500–5508. doi: 10.1128/IAI.00551-07.
    1. White NJ. Anaemia and malaria. Malar. J. 2018;17:371. doi: 10.1186/s12936-018-2509-9.
    1. Musasia, F. K. Antibody mediated clearance of ring-infected erythrocytes as a mechanism of protective immunity against Plasmodium falciparum malaria. Doctor of Natural Sciences thesis, Heidelberg University (2020).
    1. Bejon P, et al. A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya. PLoS Clin. Trials. 2006;1:e29. doi: 10.1371/journal.pctr.0010029.
    1. Midega JT, et al. Wind direction and proximity to larval sites determines malaria risk in Kilifi District in Kenya. Nat. Commun. 2012;3:674. doi: 10.1038/ncomms1672.
    1. Taylor TE, et al. Intravenous immunoglobulin in the treatment of paediatric cerebral malaria. Clin. Exp. Immunol. 1992;90:357–362. doi: 10.1111/j.1365-2249.1992.tb05851.x.
    1. Kapulu MC, Njuguna P, Hamaluba MM, Team C-SS. Controlled Human Malaria Infection in Semi-Immune Kenyan Adults (CHMI-SIKA): a study protocol to investigate in vivo Plasmodium falciparum malaria parasite growth in the context of pre-existing immunity. Wellcome Open Res. 2018;3:155. doi: 10.12688/wellcomeopenres.14909.1.
    1. Snow RW, et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet. 1997;349:1650–1654. doi: 10.1016/S0140-6736(97)02038-2.
    1. Allison AC. Protection afforded by sickle-cell trait against subtertian malareal infection. Br. Med. J. 1954;1:290–294. doi: 10.1136/bmj.1.4857.290.
    1. Radfar A, et al. Synchronous culture of Plasmodium falciparum at high parasitemia levels. Nat. Protoc. 2009;4:1899–1915. doi: 10.1038/nprot.2009.198.
    1. Boyle MJ, et al. Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development. Proc. Natl Acad. Sci. USA. 2010;107:14378–14383. doi: 10.1073/pnas.1009198107.
    1. Kobayashi K, Kato K. Evaluating the use of heparin for synchronization of in vitro culture of Plasmodium falciparum. Parasitol. Int. 2016;65:549–551. doi: 10.1016/j.parint.2016.09.002.
    1. Beeson JG, et al. Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria. FEMS Microbiol Rev. 2016;40:343–372. doi: 10.1093/femsre/fuw001.
    1. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 2006;1:2856–2860. doi: 10.1038/nprot.2006.468.
    1. Lausen B, Schumacher M. Maximally selected rank statistics. Biometrics. 1992;48:73–85. doi: 10.2307/2532740.
    1. Tyanova S, Temu T, Cox J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc. 2016;11:2301–2319. doi: 10.1038/nprot.2016.136.
    1. Cox J, et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell Proteom. 2014;13:2513–2526.
    1. Tyanova, S., Cox, J. In cancer systems biology: methods and protocols (ed Louise von Stechow). 133–148 (Springer, New York, 2018).

Source: PubMed

3
Suscribir